G
G. Ralph Corey
Researcher at Duke University
Publications - 199
Citations - 23051
G. Ralph Corey is an academic researcher from Duke University. The author has contributed to research in topics: Endocarditis & Bacteremia. The author has an hindex of 75, co-authored 198 publications receiving 21069 citations. Previous affiliations of G. Ralph Corey include Pacific Northwest National Laboratory & Purdue University.
Papers
More filters
Journal ArticleDOI
Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study
David R. Murdoch,G. Ralph Corey,Bruno Hoen,José M. Miró,Vance G. Fowler,Arnold S. Bayer,Adolf W. Karchmer,Lars Olaison,Paul A. Pappas,Philippe Moreillon,Stephen T. Chambers,Vivian H. Chu,Vicenç Falcó,David Holland,Philip Jones,John L Klein,Nigel Raymond,Kerry Read,Marie Francoise Tripodi,Riccardo Utili,Andrew Wang,Christopher W. Woods,Christopher H. Cabell +22 more
TL;DR: In the early 21st century, IE is more often an acute disease, characterized by a high rate of S aureus infection, and Mortality remains relatively high.
Journal ArticleDOI
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Vance G. Fowler,Helen W. Boucher,G. Ralph Corey,Elias Abrutyn,Adolf W. Karchmer,Mark E. Rupp,Donald P. Levine,Henry F. Chambers,Francis P. Tally,Gloria Vigliani,Christopher H. Cabell,Arthur Stanley Link,Ignace DeMeyer,Scott G. Filler,Marcus J. Zervos,Paul P. Cook,Jeffrey Parsonnet,Jack M. Bernstein,Connie S. Price,Graeme N. Forrest,Gerd Fätkenheuer,Marcelo Gareca,Susan J. Rehm,Hans Reinhardt Brodt,Alan D. Tice,Sara E. Cosgrove +25 more
TL;DR: Daptomycin (6 mg per kilogram daily) is not inferior to standard therapy for S. aureus bacteremia and right-sided endocarditis and met prespecified criteria for the noninferiority of daptomecin.
Journal ArticleDOI
Staphylococcus aureus Endocarditis A Consequence of Medical Progress
Vance G. Fowler,José M. Miró,Bruno Hoen,Christopher H. Cabell,Elias Abrutyn,Ethan Rubinstein,G. Ralph Corey,Denis Spelman,Suzanne F. Bradley,Bruno Baršić,Paul A. Pappas,Kevin J. Anstrom,Dannah Wray,Claudio Querido Fortes,Ignasi Anguera,Eugene Athan,Philip Jones,Jan van der Meer,Tom S.J. Elliott,Donald P. Levine,Arnold S. Bayer +20 more
TL;DR: Characteristics of patients with S aureus IE vary significantly by region, and further studies are required to determine the causes of regional variation.
Journal ArticleDOI
Epidemiology of Methicillin-Resistant Staphylococcus aureus
Helen W. Boucher,G. Ralph Corey +1 more
TL;DR: The trends in both nosocomial and community-associated MRSA infections are examined and recent studies of the mechanisms that allow S. aureus to become resistant to currently available drugs are explored.
Journal ArticleDOI
Clinical identifiers of complicated Staphylococcus aureus bacteremia.
Vance G. Fowler,Maren K. Olsen,G. Ralph Corey,Christopher W. Woods,Christopher H. Cabell,L. Barth Reller,Allen C. Cheng,Tara K. Dudley,Eugene Z. Oddone +8 more
TL;DR: Readily available clinical variables can help identify patients at risk for complicated SAB.